Search research articles
Contact Us
Filters
Showing results (511-520 of 636) with videos related to
Page
of 64
Sort By:
European Heart Journal
|
September 12, 2014
Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial
Benjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Circulation
|
March 10, 2016
Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials
Kristian Kragholm, Sarah A Goldstein, Qinghong Yang, et al.
JACC. Cardiovascular Interventions
|
May 12, 2018
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention
Pierluigi Tricoci, L Kristin Newby, Robert M Clare, et al.
Journal of the American Heart Association
|
March 10, 2016
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
Sean D Pokorney, Jonathan P Piccini, Susanna R Stevens, et al.
Circulation. Cardiovascular Interventions
|
May 11, 2016
Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy
Christopher J Popma, Shi Sheng, Serge Korjian, et al.
Clinical Cardiology
|
August 19, 2023
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries
Toon Wei Lim, Alan John Camm, Saverio Virdone, et al.
Journal of the American College of Cardiology
|
December 22, 2018
Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial
Cecilia C Low Wang, Juuso I Blomster, Gretchen Heizer, et al.
Circulation
|
March 8, 2017
Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis
Samuel M Lindner, Christopher B Fordyce, Anne S Hellkamp, et al.
Circulation. Arrhythmia and Electrophysiology
|
November 17, 2017
Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation)
Adam S Barnett, Sunghee Kim, Gregg C Fonarow, et al.
Lancet (London, England)
|
September 10, 2013
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
Philippe Gabriel Steg, Deepak L Bhatt, Christian W Hamm, et al.
Page
of 64
Search research articles
Search
Showing results (511-520 of 636) with videos related to
Sort By:
Page
of 64
European Heart Journal
|
September 12, 2014
Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial
Benjamin A Steinberg, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Circulation
|
March 10, 2016
Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials
Kristian Kragholm, Sarah A Goldstein, Qinghong Yang, et al.
JACC. Cardiovascular Interventions
|
May 12, 2018
Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention
Pierluigi Tricoci, L Kristin Newby, Robert M Clare, et al.
Journal of the American Heart Association
|
March 10, 2016
Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
Sean D Pokorney, Jonathan P Piccini, Susanna R Stevens, et al.
Circulation. Cardiovascular Interventions
|
May 11, 2016
Lack of Concordance Between Local Investigators, Angiographic Core Laboratory, and Clinical Event Committee in the Assessment of Stent Thrombosis: Results From the TRACER Angiographic Substudy
Christopher J Popma, Shi Sheng, Serge Korjian, et al.
Clinical Cardiology
|
August 19, 2023
Predictors of intracranial hemorrhage in patients with atrial fibrillation treated with oral anticoagulants: Insights from the GARFIELD-AF and ORBIT-AF registries
Toon Wei Lim, Alan John Camm, Saverio Virdone, et al.
Journal of the American College of Cardiology
|
December 22, 2018
Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial
Cecilia C Low Wang, Juuso I Blomster, Gretchen Heizer, et al.
Circulation
|
March 8, 2017
Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) Analysis
Samuel M Lindner, Christopher B Fordyce, Anne S Hellkamp, et al.
Circulation. Arrhythmia and Electrophysiology
|
November 17, 2017
Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation)
Adam S Barnett, Sunghee Kim, Gregg C Fonarow, et al.
Lancet (London, England)
|
September 10, 2013
Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data
Philippe Gabriel Steg, Deepak L Bhatt, Christian W Hamm, et al.
Page
of 64